Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
QMRO Home
Wolfson Institute of Preventive Medicine
Preventive Neurology Unit
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
QMRO Home
Wolfson Institute of Preventive Medicine
Preventive Neurology Unit
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
Volume
27
Pagination
775 - 776
Journal
MULTIPLE SCLEROSIS JOURNAL
Issue
2_SUPPL
ISSN
1352-4585
Metadata
Show full item record
Authors
Vickaryous, N; Asardag, AN; Chance, R; Jones, M; Bestwick, J; Shah, SN; George, K; Schmierer, K; Giovannoni, G; Baker, D
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/75630
Collections
Preventive Neurology Unit
[101]